Scarica l'app Stockscreener
98.50
1.55%
-1.55
Dopo l'orario di chiusura:
98.17
-0.33
-0.34%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$100.05
Aprire:
$96.94
Volume 24 ore:
11.00M
Relative Volume:
1.63
Capitalizzazione di mercato:
$145.53B
Reddito:
$16.75B
Utile/perdita netta:
$1.85B
Rapporto P/E:
78.80
EPS:
1.25
Flusso di cassa netto:
$2.37B
1 W Prestazione:
-2.28%
1M Prestazione:
-6.07%
6M Prestazione:
+17.51%
1 anno Prestazione:
+44.58%
Intervallo 1D:
$96.65
$99.86
Intervallo di 1 settimana:
$96.65
$101.28
Portata 52W:
$66.80
$107.17
Boston Scientific Corp Stock (BSX) Company Profile
Nome
Boston Scientific Corp
Settore
Industria
Telefono
508-683-4000
Indirizzo
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Confronta BSX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
98.50 | 145.53B | 16.75B | 1.85B | 2.37B | 1.25 |
|
ABT
Abbott Laboratories
|
131.63 | 229.74B | 41.95B | 13.40B | 6.35B | 7.65 |
|
SYK
Stryker Corp
|
368.15 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
87.89 | 114.37B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.98 | 42.24B | 5.72B | 4.17B | 259.90M | 6.97 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Downgrade | Needham | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-02-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-20 | Ripresa | Citigroup | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-27 | Aggiornamento | Needham | Hold → Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-05-26 | Downgrade | Needham | Buy → Hold |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Buy |
| 2019-12-30 | Reiterato | Cowen | Outperform |
| 2019-12-19 | Downgrade | Needham | Strong Buy → Buy |
| 2019-09-05 | Ripresa | JP Morgan | Overweight |
| 2019-09-03 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-10-02 | Reiterato | Morgan Stanley | Overweight |
| 2018-09-07 | Reiterato | Needham | Strong Buy |
| 2018-09-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-07-06 | Reiterato | Needham | Strong Buy |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-04-26 | Reiterato | Needham | Strong Buy |
Mostra tutto
Boston Scientific Corp Borsa (BSX) Ultime notizie
Boston Scientific Sued Over Endoscopic Medical Device Patent - Bloomberg Law News
Boston Scientific (BSX) Faces Pressure from New Tariffs - GuruFocus
Stryker, Boston Scientific down as new tariffs impact medtech industry - Seeking Alpha
Price Over Earnings Overview: Boston Scientific - Benzinga
Is Boston Scientific (NYSE:BSX) A Risky Investment? - Yahoo Finance
Boston Scientific CEO Michael Mahoney sells $16.4 million in stock By Investing.com - Investing.com Philippines
No benefit found for cerebral protection device in TAVR - BioWorld MedTech
Boston Scientific CEO Michael Mahoney sells $16.4 million in stock - Investing.com India
Boston Scientific closes Bolt Medical acquisition - MassDevice
Evercore ISI Adjusts Boston Scientific Price Target to $110 From $112, Maintains Outperform Rating - MarketScreener
Boston Scientific announces conference call discussing first quarter 2025 results - Quantisnow
FDA Approval Boosts Boston Scientific's (BSX) Investment in Bolt Medical - GuruFocus
FDA clears Bolt Medical’s IVL system, backing Boston Scientific’s $664m buyout - Yahoo Finance
Boston Scientific (BSX): Among the Best Healthcare Stocks to Buy According to Billionaires - Insider Monkey
Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
FDA clears Boston Scientific Bolt IVL system - MassDevice
Boston Scientific Farapulse PFA system shows superiority in head-to-head study with Medtronic cryoablation system - MassDevice
2024 Research: Urinary Guidewire Market Set to Reach Over $266 Million by 2031, Tech Advancements and Shift Towards Minimally Invasive Surgeries - GlobeNewswire Inc.
Boston Scientific Co. (NYSE:BSX) is Homestead Advisers Corp's 8th Largest Position - MarketBeat
Boston Scientific Corporation (NYSE:BSX) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - Yahoo Finance
Boston Scientific to acquire SoniVie - Today's Medical Developments
$100 Invested In Boston Scientific 5 Years Ago Would Be Worth This Much Today - Benzinga
International Expansion, Product Launches Support BSX Stock - Yahoo Finance
Goldman Sachs Adjusts Price Target on Boston Scientific to $116 From $119, Maintains Buy Rating - Marketscreener.com
The Zacks Analyst Blog Highlights Tesla, The Home Depot, Boston Scientific, Frequency Electronics and Bridger Aerospace - Yahoo Finance
Top Stock Reports for Tesla, Home Depot & Boston Scientific - MSN
The Zacks Analyst Blog Boston Scientific, Abbott and Medtronic - Yahoo Finance
Boston Scientific SVP Vance Brown sells shares worth $486,702 By Investing.com - Investing.com Australia
Market Makes A Big Shift: DoorDash, Heico, Boston Scientific In Focus - Investor's Business Daily
Boston Scientific SVP Vance Brown sells shares worth $486,702 - Investing.com India
Returns Are Gaining Momentum At Boston Scientific (NYSE:BSX) - Yahoo Finance
Boston Scientific CEO joins the $20M compensation club - NBC Boston
Boston Scientific CEO gets 14% boost in compensation - The Business Journals
November 21st Options Now Available For Boston Scientific (BSX) - Nasdaq
RBC Capital maintains Outperform on Boston Scientific shares, $116 target - Investing.com
Investors more bullish on Boston Scientific (NYSE:BSX) this week as stock grows 5.6%, despite earnings trending downwards over past five years - Yahoo Finance
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Boston Scientific Corporation Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – BSX - Business Wire
Form DEF 14A BOSTON SCIENTIFIC CORP For: Mar 19 - StreetInsider
Medtronic, Abbott Block Boston Scientific Heart Valve IP - Law360
Is Boston Scientific Corporation (BSX) the Top Stock to Buy According to Marshall Wace LLP? - Insider Monkey
Boston Scientific (BSX) Gains As Market Dips: What You Should Know - Yahoo Finance
Boston Scientific (BSX) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Neurotech Devices Market Is Booming Worldwide 2025-2032 | - openPR
Here's Why We Think Boston Scientific (NYSE:BSX) Is Well Worth Watching - Yahoo Finance
Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now? - Yahoo Finance
Boston Scientific’s SWOT analysis: medtech giant’s stock poised for growth By Investing.com - Investing.com South Africa
Boston Scientific’s SWOT analysis: medtech giant’s stock poised for growth - Investing.com
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Boston Scientific (NYSE:BSX) Sees 4% Price Rise Following Strong Earnings Report - Yahoo Finance
Boston Scientific Gains 42.2% in a Year: What's Driving the Stock? - Yahoo Finance
Boston Scientific price target raised to $110 from $100 at Bernstein - MSN
Boston Scientific Corp Azioni (BSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.47%
1.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):